Related Experiment Videos
Binding of native and thrombin activated factor VIII to platelets.
Thrombosis Research
|September 1, 1983
Summary
Human Factor VIII (FVIII) binds to activated platelets, with thrombin-activated FVIII showing significant association. This binding is reversible, suggesting a mechanism for in vivo Factor X activator complex formation.
Area of Science:
- Hematology
- Biochemistry
- Molecular Biology
Background:
- Human Factor VIII (FVIII) is a crucial protein in the coagulation cascade.
- Platelets play a central role in hemostasis and thrombosis.
- The interaction between FVIII and platelets is not fully understood.
Purpose of the Study:
- To investigate the interaction between purified human Factor VIII and platelets.
- To determine the binding characteristics of Factor VIII to both released and non-released platelets.
- To explore the potential mechanism for in vivo Factor X activator complex formation.
Main Methods:
- Discontinuous albumin gradient centrifugation was employed to study FVIII-platelet interactions.
- Purified Factor VIII complex and thrombin-activated Factor VIII were incubated with released and non-released platelets.
- Factor VIII activity associated with platelets was quantified.
Main Results:
- Approximately 10% of purified Factor VIII complex activity associated with released platelets.
- About 50% of thrombin-activated Factor VIII activity bound to released platelets.
- Factor VIII binding to platelets was reversible upon dilution, and minimal binding occurred with non-released platelets.
Conclusions:
- Activated platelets exhibit significant binding capacity for human Factor VIII.
- The reversible nature of FVIII binding suggests dynamic interactions.
- These findings propose a mechanism for the in vivo formation of the Factor X activator complex involving platelet-bound FVIII.